Catalyst Wire Dossier Catalyst Wire Dossier

Theracurmin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Theracurmin, covering 2023-09-28 to 2023-09-28. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Theracurmin for Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

See pricing